Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T65879 | Target Info | |||
Target Name | Inhibitor of nuclear factor kappa-B kinase alpha (IKKA) | ||||
Synonyms | Transcription factor 16; TCF16; TCF-16; Nuclear factor NFkappaB inhibitor kinase alpha; Nuclear factor NF-kappa-B inhibitor kinase alpha; NFKBIKA; Inhibitory kappa B kinasea; Inhibitor of nuclear factor kappa-B kinase subunit alpha; IkappaB kinase A; IkBKA; IKK1; IKK-alpha; IKK-A; I-kappa-B kinase alpha; I-kappa-B kinase 1; I kappa-B kinase alpha; Conserved helix-loop-helix ubiquitous kinase | ||||
Target Type | Literature-reported Target | ||||
Gene Name | CHUK | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 1 Acyltransferases | + | |||
Interacting Target Name | Nuclear receptor coactivator 3 (NCOA3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TRAM-1; TRAM1; Thyroid hormone receptor activator molecule 1; Steroid receptor coactivator protein 3; SRC-3; Receptor-associated coactivator 3; RAC-3; RAC3; PCIP; NCoA-3; Class E basic helix-loop-helix protein 42; CBP-interacting protein; bHLHe42; Amplified in breast cancer-1 protein; Amplified in breast cancer 1 protein; AIB1 (SRC-3); AIB-1; AIB1; ACTR | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Biochemical Activity | [3] | |||
4 | Co-localization | [4] | |||
5 | Reconstituted Complex | [2] | |||
Cell division cycle proteins | [+] 1 Cell division cycle proteins | + | |||
Interacting Target Name | Hsp90 co-chaperone Cdc37 (CDC37) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | p50Cdc37; Hsp90 co-chaperone Cdc37, N-terminally processed; Hsp90 chaperone protein kinase-targeting subunit; CDC37A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Reconstituted Complex | [6] | |||
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [8] | |||
Kinases | [+] 4 Kinases | + | |||
Interacting Target Name | Inhibitor of nuclear factor kappa-B kinase beta (IKKB) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Nuclear factor NF-kappa-B inhibitor kinase beta; NFKBIKB; Inhibitory kappa B kinase b; Inhibitor of nuclear factor kappa-B kinase subunit beta; IKK-beta; IKKbeta; IKK-B; IKK-2; IKK2; IkBKB; I-kappa-B-kinase beta; IkappaB kinase beta; I-kappa-B kinase 2; IkappaB kinase 2 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Affinity Capture-Western | [9] | |||
3 | Biochemical Activity | [10] | |||
4 | Co-fractionation | [11] | |||
5 | Co-localization | [12] | |||
6 | Co-purification | [13] | |||
7 | Reconstituted Complex | [9] | |||
Interacting Target Name | Serine/threonine-protein kinase NIK (MAP3K14) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NIK; NF-kappa-beta-inducing kinase; Mitogen-activated protein kinase kinase kinase 14; HsNIK | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [14] | |||
2 | Affinity Capture-Western | [15] | |||
3 | Biochemical Activity | [16] | |||
4 | Co-localization | [12] | |||
5 | Reconstituted Complex | [17] | |||
6 | Yeast two hybrid | [18] | |||
Interacting Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; Protein kinase B; PKB alpha; PKB | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [19] | |||
2 | Biochemical Activity | [19] | |||
3 | Co-localization | [12] | |||
Interacting Target Name | TGF-beta-activated kinase 1 (MAP3K7) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transforming growth factor-beta-activated kinase 1; TAK1; Mitogen-activated protein kinase kinase kinase 7 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [20] | |||
2 | Co-localization | [12] | |||
Peptidases | [+] 1 Peptidases | + | |||
Interacting Target Name | JUN activation domain binding protein (COPS5) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Signalosome subunit 5; SGN5; Jun activation domain-binding protein 1; JAB1; CSN5; COP9 signalosome complex subunit 5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Biochemical Activity | [22] | |||
Transcription regulators | [+] 2 Transcription regulators | + | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [23] | |||
2 | Biochemical Activity | [24] | |||
3 | Yeast two hybrid | [23] | |||
Interacting Protein Name | Transcription factor p65 (RELA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NFKB3; p65 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Biochemical Activity | [25] | |||
Other proteins | [+] 6 Other proteins | + | |||
Interacting Protein Name | NF-kappa-B essential modulator (IKBKG) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AMCBX1; FIP.3; FIP3; Fip3p; IKK.gamma; IMD33; IP; IP1; IP2; IPD2; NEMO; ZC2HC9 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [5] | |||
2 | Affinity Capture-Western | [26] | |||
3 | Biochemical Activity | [27] | |||
4 | Co-fractionation | [11] | |||
5 | Co-purification | [28] | |||
6 | Reconstituted Complex | [29] | |||
Interacting Target Name | Beta-arrestin-2 (ARRB2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Non-visual arrestin-3; Betaarrestin2; Arrestin beta-2; Arrestin beta2; ARR2; ARB2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [30] | |||
2 | Co-localization | [12] | |||
Interacting Protein Name | B-cell lymphoma/leukemia 10 (BCL10) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CARMEN; CIPER; CLAP; IMD37; c.E10; mE10 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Biochemical Activity | [32] | |||
Interacting Protein Name | NF-kappa-B inhibitor alpha (NFKBIA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IKBA; MAD.3; NFKBI | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [33] | |||
2 | Biochemical Activity | [34] | |||
Interacting Protein Name | NF-kappa-B inhibitor beta (NFKBIB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IKBB; TRIP9 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [35] | |||
2 | Biochemical Activity | [36] | |||
Interacting Target Name | Tumor necrosis factor (TNF) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumour necrosis factor alpha; Tumour necrosis factor; Tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor; TNFSF2; TNF-alpha; TNFalpha; TNF-a; TNFA; TNF alpha; Cachectin | ||||
Evidence Score (E-score) | 1 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [37] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. Mol Endocrinol. 2005 Oct;19(10):2451-65. | ||||
REF 2 | Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. Mol Cell Biol. 2002 May;22(10):3549-61. | ||||
REF 3 | Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell. 2004 Sep 24;15(6):937-49. | ||||
REF 4 | Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol Cell. 2005 Apr 1;18(1):71-82. | ||||
REF 5 | Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity. 2011 Sep 23;35(3):426-40. | ||||
REF 6 | TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell. 2002 Feb;9(2):401-10. | ||||
REF 7 | A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting protein. Mol Cell Proteomics. 2010 Feb;9(2):255-70. | ||||
REF 8 | Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6. PLoS One. 2012;7(2):e32215. | ||||
REF 9 | Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science. 2000 Sep 1;289(5484):1550-4. | ||||
REF 10 | A20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activity. J Biol Chem. 2011 Sep 16;286(37):32277-88. | ||||
REF 11 | Role of IKKgamma/nemo in assembly of the Ikappa B kinase complex. J Biol Chem. 2001 Feb 9;276(6):4494-500. | ||||
REF 12 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 13 | Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science. 1998 Aug 28;281(5381):1360-3. | ||||
REF 14 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 15 | Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor. J Biol Chem. 2010 May 28;285(22):17148-55. | ||||
REF 16 | The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 1999 Mar 18;398(6724):252-6. | ||||
REF 17 | Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40. J Biol Chem. 2001 May 4;276(18):14602-6. | ||||
REF 18 | Identification and characterization of an IkappaB kinase. Cell. 1997 Jul 25;90(2):373-83. | ||||
REF 19 | NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 1999 Sep 2;401(6748):82-5. | ||||
REF 20 | Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation. J Biol Chem. 1999 Apr 9;274(15):10641-8. | ||||
REF 21 | Endothelial CSN5 impairs NF-B activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions. Thromb Haemost. 2013 Jul;110(1):141-52. | ||||
REF 22 | Crosstalk between the NF-kappaB activating IKK-complex and the CSN signalosome. J Cell Mol Med. 2010 Jun;14(6B):1555-68. | ||||
REF 23 | Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression. J Biol Chem. 2004 Jan 30;279(5):3509-15. | ||||
REF 24 | Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell. 2007 Apr 13;26(1):75-87. | ||||
REF 25 | IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol. 2006 Jan;26(2):457-71. | ||||
REF 26 | IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature. 1998 Sep 17;395(6699):297-300. | ||||
REF 27 | Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science. 2006 Feb 24;311(5764):1141-6. | ||||
REF 28 | Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000 Oct 13;103(2):351-61. | ||||
REF 29 | Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity. Mol Cell Biol. 2006 Dec;26(24):9209-19. | ||||
REF 30 | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12011-6. | ||||
REF 31 | vCLAP, a caspase-recruitment domain-containing protein of equine Herpesvirus-2, persistently activates the Ikappa B kinases through oligomerization of IKKgamma. J Biol Chem. 2001 Feb 2;276(5):3183-7. | ||||
REF 32 | IB kinase phosphorylation of TRAF4 downregulates innate immune signaling. Mol Cell Biol. 2012 Jul;32(13):2479-89. | ||||
REF 33 | Tautomycetin suppresses the TNFalpha/NF-kappaB pathway via inhibition of IKK activation. Int J Oncol. 2008 Nov;33(5):1027-35. | ||||
REF 34 | A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 1997 Aug 7;388(6642):548-54. | ||||
REF 35 | Disruption of NF-kappa B signaling and chemokine gene activation by retroviral mediated expression of IKK gamma/NEMO mutants. Virology. 2001 Aug 1;286(2):422-33. | ||||
REF 36 | IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science. 1997 Oct 31;278(5339):866-9. | ||||
REF 37 | Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell. 2009 Dec 11;36(5):831-44. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.